Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

Willem A Mak; Johannes G M Koeleman; David S Y Ong

doi:https://doi.org/10.1016/j.jcv.2022.105158

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

Willem A Mak, Johannes G M Koeleman, David S Y Ong

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	105158
Journal	Journal of clinical virology
Volume	150-151
DOIs	https://doi.org/10.1016/j.jcv.2022.105158
Publication status	Published - Jun 2022

Keywords

Antibodies, Viral
COVID-19
Enzyme-Linked Immunospot Assay
Humans
SARS-CoV-2
T-Lymphocytes

Access to Document

https://doi.org/10.1016/j.jcv.2022.105158

Cite this

@article{290461a5398c4f89974ade38e4c64636,

title = "Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot{\textregistered} Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals",

keywords = "Antibodies, Viral, COVID-19, Enzyme-Linked Immunospot Assay, Humans, SARS-CoV-2, T-Lymphocytes",

author = "Mak, {Willem A} and Koeleman, {Johannes G M} and Ong, {David S Y}",

year = "2022",

month = jun,

doi = "https://doi.org/10.1016/j.jcv.2022.105158",

language = "English",

volume = "150-151",

pages = "105158",

journal = "Journal of clinical virology",

issn = "1386-6532",

publisher = "Elsevier",

}

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals. / Mak, Willem A; Koeleman, Johannes G M; Ong, David S Y.
In: Journal of clinical virology, Vol. 150-151, 06.2022, p. 105158.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

AU - Mak, Willem A

AU - Koeleman, Johannes G M

AU - Ong, David S Y

PY - 2022/6

Y1 - 2022/6

KW - Antibodies, Viral

KW - COVID-19

KW - Enzyme-Linked Immunospot Assay

KW - Humans

KW - SARS-CoV-2

KW - T-Lymphocytes

U2 - https://doi.org/10.1016/j.jcv.2022.105158

DO - https://doi.org/10.1016/j.jcv.2022.105158

M3 - Article

C2 - 35447515

SN - 1386-6532

VL - 150-151

SP - 105158

JO - Journal of clinical virology

JF - Journal of clinical virology

ER -